Amylin in the insulin resistance of patients with rheumatoid arthritis.
CONCLUSIONS: IR in RA does not appear to be mediated by amylin. This would imply that the mechanisms associated with IR in RA patients differ from those at work in type 2 diabetes.
PMID: 29352842 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research
More News: Arthritis | Diabetes | Diabetes Type 2 | Endocrinology | Insulin | Methotrexate | Rheumatoid Arthritis | Rheumatology | Study